十一月 2025
- Home
- Biovac
十一月 2025的Biovac市场份额分析
To be the leading biopharmaceutical company in Africa, committed to protecting life through the development, end-to-end manufacture & global supply of vaccines and other biologicals. OUR VALU…
Biovac(包含公司地区分支机构)
查看更多网站流量和参与度信息- biovac.co.za
Biovac收入截至 十一月 2025为 15M - 25M
Biovac主要域名产生的收入
3 年中Biovac主要域名的收入
Biovac主要域名的收入
Biovac热门域名的总访问量
了解Biovac市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Biovac热门域名的平均访问时长
分析Biovac参与度指标。
过去 3 个月的平均访问时长
子公司明细
Biovac热门域名的平均页面浏览量
了解Biovac如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Biovac 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Biovac launches cholera vaccine clinical trial.Biovac, a South African biopharmaceutical company and client of the International Finance Corporation (IFC), has launched clinical trials for the country's first locally developed oral cholera vaccine - marking a significant milestone for Africa's vaccine manufacturing landscape.
十一月 24, 2025阅读更多
新闻Biovac launches state-of-the-art product development laboratory.Biovac, a leading South African biopharmaceutical company, is launching a state-of-the-art product development laboratory at its Cape Town facility, to expand the company's ability to develop vaccines and other therapeutics.
十一月 6, 2025阅读更多
新闻Biovac expands facilities to Cape Town, South Africa.The project primarily focused on Biovac's state-of-the-art vaccine manufacturing facility in Cape Town, which aims to scale up vaccine production to meet global standards.
七月 31, 2025阅读更多
查看 Biovac 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。